Upgrade to SI Premium - Free Trial

Capricor Therapeutics (CAPR)

18.91 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald July 15, 2026 7:48 AM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: Jul 09 July 14, 2026 5:06 PM - SEC Filing Capricor Therapeutics (CAPR) Reiterates Overweight Rating Ahead of Upcoming PDUFA July 7, 2026 7:18 AM - StreetInsider Form 4 CAPRICOR THERAPEUTICS, For: Jun 25 Filed by: Bergmann Anthony June 29, 2026 9:30 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: Jun 25 Filed by: Krasney Karen June 29, 2026 9:30 PM - SEC Filing Capricor Therapeutics (CAPR) 4500 contracts of August 30 calls and 2900 contracts of August 20 puts trade June 29, 2026 5:58 AM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: Jun 26 June 26, 2026 5:15 PM - SEC Filing FDA to review Capricor's DMD therapy at July advisory meeting June 26, 2026 10:02 AM - StreetInsider Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy June 26, 2026 10:02 AM - Globe NewsWire Capricor shares five-year deramiocel data at DMD conference June 26, 2026 9:05 AM - StreetInsider Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference June 26, 2026 9:05 AM - Globe NewsWire Form 4 CAPRICOR THERAPEUTICS, For: Jun 22 Filed by: Krasney Karen June 24, 2026 8:00 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: Jun 22 Filed by: Bergmann Anthony June 24, 2026 8:00 PM - SEC Filing Form 8-K CAPRICOR THERAPEUTICS, For: Jun 04 June 8, 2026 4:05 PM - SEC Filing Capricor Therapeutics to Present at Upcoming Investor Conferences June 8, 2026 9:25 AM - Globe NewsWire Form 4 CAPRICOR THERAPEUTICS, For: May 26 Filed by: Maurer Michael T May 28, 2026 9:55 PM - SEC Filing Form 3 CAPRICOR THERAPEUTICS, For: May 25 Filed by: Maurer Michael T May 28, 2026 9:52 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: May 18 Filed by: Bergmann Anthony May 19, 2026 4:15 PM - SEC Filing Form 144/A CAPRICOR THERAPEUTICS, Filed by: Musket David B May 19, 2026 2:41 PM - SEC Filing Form 144 CAPRICOR THERAPEUTICS, Filed by: Musket David B May 19, 2026 11:40 AM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: May 13 Filed by: Litvack Frank May 14, 2026 5:00 PM - SEC Filing Form 10-Q CAPRICOR THERAPEUTICS, For: Mar 31 May 13, 2026 5:21 PM - SEC Filing B.Riley Reiterates Buy Rating on Capricor Therapeutics (CAPR) May 13, 2026 4:15 AM - StreetInsider Capricor Therapeutics (CAPR) Misses Q1 EPS by 7c May 12, 2026 4:13 PM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: May 12 May 12, 2026 4:07 PM - SEC Filing Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update May 12, 2026 4:05 PM - Globe NewsWire Capricor sues NS Pharma over Duchenne therapy distribution deal May 8, 2026 7:15 AM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: May 07 May 7, 2026 4:41 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: May 01 Filed by: Krasney Karen May 4, 2026 4:30 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: May 01 Filed by: Bergmann Anthony May 4, 2026 4:30 PM - SEC Filing Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12 May 4, 2026 4:05 PM - Globe NewsWire Full Article List